IGC posts updated life sciences presentation on website; no financial or clinical updates

IGC Pharma, Inc.

Presentation covers low-dose THC drug formulation and disease treatment initiatives.
Also highlights cannabinoid consumer product lines including Holief and Sunday Seltzer.
No new clinical trial results, partnerships, or revenue guidance disclosed.
Presentation available at igcpharma.com and filed as Exhibit 99.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.